Related Experiment Video
Updated: Jul 25, 2025

Identifying Caspases and their Motifs that Cleave Proteins During Influenza A Virus Infection
Published on: July 21, 2022
RNA Overwriting of Cellular mRNA by Cas13b-Directed RNA-Dependent RNA Polymerase of Influenza A Virus
Shinzi Ogasawara1, Sae Ebashi1
1Department of Biology, Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto 390-8621, Nagano, Japan.
Abstract:
Dysregulation of mRNA processing results in diseases such as cancer. Although RNA editing technologies attract attention as gene therapy for repairing aberrant mRNA, substantial sequence defects arising from mis-splicing cannot be corrected by existing techniques using adenosine deaminase acting on RNA (ADAR) due to the limitation of adenosine-to-inosine point conversion. Here, we report an RNA editing technology called "RNA overwriting" that overwrites the sequence downstream of a designated site on the target RNA by utilizing the RNA-dependent RNA polymerase (RdRp) of the influenza A virus. To enable RNA overwriting within living cells, we developed a modified RdRp by introducing H357A and E361A mutations in the polymerase basic 2 of RdRp and fusing the C-terminus with catalytically inactive Cas13b (dCas13b). The modified RdRp knocked down 46% of the target mRNA and further overwrote 21% of the mRNA. RNA overwriting is a versatile editing technique that can perform various modifications, including addition, deletion, and mutation introduction, and thus allow for repair of the aberrant mRNA produced by dysregulation of mRNA processing, such as mis-splicing.
Insights
This study introduces RNA overwriting, a novel gene therapy. This technique repairs aberrant mRNA by overwriting sequences, offering a versatile solution for diseases caused by mRNA processing dysregulation.
Area of Science:
- Molecular Biology
- Gene Therapy
- RNA Editing Technologies
Background:
- Dysregulation of messenger RNA (mRNA) processing is implicated in various diseases, including cancer.
- Current RNA editing technologies, such as adenosine deaminase acting on RNA (ADAR), are limited to adenosine-to-inosine point conversions and cannot correct substantial sequence defects like mis-splicing.
- There is a need for advanced RNA editing tools capable of broader sequence repair.
Purpose of the Study:
- To develop a novel RNA editing technology for repairing aberrant mRNA, specifically addressing limitations of existing methods.
- To enable sequence overwriting downstream of a target site on mRNA within living cells.
- To demonstrate the versatility of the new RNA editing technique for various modifications.
Main Methods:
- Development of a novel RNA editing technology termed 'RNA overwriting'.
- Utilized the RNA-dependent RNA polymerase (RdRp) from influenza A virus.
- Engineered a modified RdRp by introducing specific mutations (H357A and E361A) and fusing it with catalytically inactive Cas13b (dCas13b) for targeted delivery and activity within cells.
Main Results:
- The modified RdRp successfully knocked down 46% of the target mRNA.
- The RNA overwriting technology achieved a 21% overwriting rate on the target mRNA.
- Demonstrated the capability of RNA overwriting for diverse modifications, including insertions, deletions, and point mutations.
Conclusions:
- RNA overwriting is a versatile and effective RNA editing technology.
- This technique can repair aberrant mRNA resulting from mRNA processing dysregulation, such as mis-splicing.
- RNA overwriting holds potential as a therapeutic strategy for diseases linked to mRNA processing defects.
Related Concept Videos
Leaky Scanning
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Viruses with RNA Genomes
Experimental RNAi
RNA Editing
Viral Mutations

